These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11701981)

  • 21. Evaluation of preservative efficacy in pharmaceutical products: the use of psychrotolerant, low-nutrient preferring microbes in challenge tests.
    Charnock C; Otterholt E
    J Clin Pharm Ther; 2012 Oct; 37(5):558-64. PubMed ID: 22591271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbial limits reviewed: the basis for unique Australian regulatory requirements for microbial quality of non-sterile pharmaceuticals.
    Tang S
    PDA J Pharm Sci Technol; 1998; 52(3):100-9. PubMed ID: 9691672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fungus-benzimidazole interactions: a prerequisite to deploying egg-parasitic fungi Paecilomyces lilacinus and Verticillium chlamydosporium as biocontrol agents against fascioliasis and amphistomiasis in ruminant livestock.
    Singh RK; Sanyal PK; Patel NK; Sarkar AK; Santra AK; Pal S; Mandal SC
    J Helminthol; 2010 Jun; 84(2):123-31. PubMed ID: 19698195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbial Stability of Pharmaceutical and Cosmetic Products.
    Dao H; Lakhani P; Police A; Kallakunta V; Ajjarapu SS; Wu KW; Ponkshe P; Repka MA; Narasimha Murthy S
    AAPS PharmSciTech; 2018 Jan; 19(1):60-78. PubMed ID: 29019083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of the antimicrobial effectiveness test as USP chapter <51>.
    Sutton SV; Porter D
    PDA J Pharm Sci Technol; 2002; 56(6):300-11. PubMed ID: 12497767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Paecilomyces lilacinus--sensitivity to disinfectants].
    Volná F; Máderová E
    Cesk Epidemiol Mikrobiol Imunol; 1990 Sep; 39(5):315-7. PubMed ID: 2150619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The preservation of some oral liquid preparations. The replacement of chloroform by other preservatives.
    van Doorne H; Leijen JB
    Pharm World Sci; 1994 Feb; 16(1):18-21. PubMed ID: 8156044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion of food waste into biofertilizer for the biocontrol of root knot nematode by Paecilomyces lilacinus.
    Yu Z; Zhang YC; Zhang X; Wang Y
    Environ Technol; 2015; 36(24):3148-58. PubMed ID: 26075798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial preservative use in parenteral products: past and present.
    Meyer BK; Ni A; Hu B; Shi L
    J Pharm Sci; 2007 Dec; 96(12):3155-67. PubMed ID: 17722087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of impedance test for testing effectiveness of drug preservatives].
    Zareba T; Tyski S
    Med Dosw Mikrobiol; 2003; 55(1):89-96. PubMed ID: 12908420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical voriconazole as a novel treatment for fungal keratitis.
    Sponsel W; Chen N; Dang D; Paris G; Graybill J; Najvar LK; Zhou L; Lam KW; Glickman R; Scribbick F
    Antimicrob Agents Chemother; 2006 Jan; 50(1):262-8. PubMed ID: 16377696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterologous expression of VHb can improve the yield and quality of biocontrol fungus Paecilomyces lilacinus, during submerged fermentation.
    Zhang S; Wang J; Wei Y; Tang Q; Ali MK; He J
    J Biotechnol; 2014 Oct; 187():147-53. PubMed ID: 25087739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Paecilomyces lilacinus (strain 251) for the control of Radopholus similis in banana.
    Mendoza A; Sikora RA; Kiewnick S
    Commun Agric Appl Biol Sci; 2004; 69(3):365-72. PubMed ID: 15759436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-consumer use efficacies of preservatives in personal care and topical drug products: relationship to preservative category.
    Ravita TD; Tanner RS; Ahearn DG; Arms EL; Crockett PW
    J Ind Microbiol Biotechnol; 2009 Jan; 36(1):35-8. PubMed ID: 18802729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing the nematophagous biological control strain Paecilomyces lilacinus 251 for paecilotoxin production.
    Khan A; Williams K; Nevalainen H
    FEMS Microbiol Lett; 2003 Oct; 227(1):107-11. PubMed ID: 14568155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neglected and emerging fungal infections: review of hyalohyphomycosis by Paecilomyces lilacinus focusing in disease burden, in vitro antifungal susceptibility and management.
    Antas PR; Brito MM; Peixoto É; Ponte CG; Borba CM
    Microbes Infect; 2012 Jan; 14(1):1-8. PubMed ID: 21907304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mutant of the nematophagous fungus Paecilomyces lilacinus (Thom) is a novel biocontrol agent for Sclerotinia sclerotiorum.
    Yang F; Abdelnabby H; Xiao Y
    Microb Pathog; 2015 Dec; 89():169-76. PubMed ID: 26521137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Separation, quantification and characterisation of the pigment produced by
    Yu X; Xing X; Dong Q; Shi K; Yan R
    Nat Prod Res; 2022 Oct; 36(19):5053-5057. PubMed ID: 33896278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyalohyphomycosis by Paecilomyces lilacinus in a renal transplant patient and a review of human Paecilomyces species infections.
    Castro LG; Salebian A; Sotto MN
    J Med Vet Mycol; 1990; 28(1):15-26. PubMed ID: 2194015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examination of microbiological quality of pharmaceutical raw materials.
    Bomblies L; Weiss C; Beckmann G
    Pharmeur Sci Notes; 2007 Sep; 2007(1):1-7. PubMed ID: 17993088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.